{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-028500","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2024-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.920560+00:00","generated_at":"2026-05-31T19:11:07.934431+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TenX Keane Acquisition extends business combination deadline to August 18, 2024 via $66,667 note from Citius Pharma","bullets":["Citius Pharma deposited $66,667 into trust to extend deadline from July 18 to August 18, 2024; fourth monthly extension.","Prior extensions occurred on April 26, May 17, and June 17, 2024; Company can extend up to November 18, 2024.","Promissory note is unsecured, bears no interest, and is repayable only upon closing if trust balance >= $2M.","Extension funded under Merger Agreement; Note is evidenced by Exhibit 10.4 to this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-028500","json":"https://secwatch.observer/filing/0001493152-24-028500.json","markdown":"https://secwatch.observer/filing/0001493152-24-028500.md","text":"https://secwatch.observer/filing/0001493152-24-028500.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224028500/0001493152-24-028500-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224028500/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T19:11:07.934431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}